Skip to main content
. 2015 Feb 5;20(3):247–256. doi: 10.1634/theoncologist.2014-0392

Figure 2.

Figure 2.

Kaplan Meier charts summarizing overall survival of the cohort according to biomarker over- or underexpression (A–E). (F): Kaplan Meier chart describing overall survival in patients with zero, one, two, or three unfavorable staining characteristics (TOP2A >2, BARD1 ≤2+, and Ki-67 >10%).